by Jessica Casebolt | May 23, 2023 | D.C. News, Tea Leaves
Congressional Democrats are having second thoughts about taking back unspent coronavirus funds as part of a debt limit deal, concerned that doing so could have serious consequences for myriad public health initiatives. House Appropriations Ranking Member Rosa DeLauro...
by Jessica Casebolt | May 23, 2023 | Providers, Tea Leaves
Minnesota is poised to become the first state to enact legislation establishing a board that will set minimum wages and benefits for nursing home workers. The measure is the latest effort by states to help attract workers to post-acute care as demand for those...
by Jessica Casebolt | May 23, 2023 | Opioid/Substance Use Disorders, Tea Leaves
The Biden administration called on Congress Monday to pass a bill aimed at tackling fentanyl trafficking in the U.S., which would see the synthetic opioid raised to the highest classification of illegal drugs. The bill would permanently place all fentanyl-related...
by Jessica Casebolt | May 16, 2023 | M&A, Tea Leaves
The U.S. Federal Trade Commission is expected to file a lawsuit as early as Tuesday to block Amgen Inc’s $27.8 billion deal to buy Horizon Therapeutics PLC. Amgen struck a deal last year to buy Horizon to strengthen its rare diseases drugs portfolio. The company...
by Jessica Casebolt | May 16, 2023 | Life Sciences, Tea Leaves
CVS Health is closing down its clinical trials arm just two years after its launch. The company began its collaboration with pharmaceutical companies in 2021 and will shut it down at the end of 2024. To date,CVS Health has worked with more than 30 drugmakers on 50...
Recent Comments